Breaking News

mAbxience Continues Manufacturing Capacity Expansion

Secures its second 4,000L ABEC Custom Single Run (CSR) bioreactor to increase manufacturing capacity at its Leon, Spain facility.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ABEC, a global provider of engineered solutions and services for biotech manufacturing, said that mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an additional ABEC 4,000L CSR bioreactor. Following the successful delivery of the first 4,000L CSR bioreactor in 2021, mAbxience again selected ABEC’s innovative single-use technology to increase its CDMO business and capacity. In April 2022, and after being approved in Europe, Canada and Japan among others, the U.S. F...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters